FDA NDC Directory · JSON-LD · Markdown

Regadenoson

NDC 67457-994 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerMylan Institutional LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA213856
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsREGADENOSON (.4 mg/5mL)
Marketing started20230921
Marketing ended20260630
Package count1

External sources

Source: openFDA. Public-domain (CC0).